We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > bladder cancer drug

News List

LIPAC, Huons ink licensing deal for bladder cancer drug candidate biospectrumasia
September 18, 2019
Lipac was established in 1972 as an aerial lift specialist and now also offers telehandlers.
Clovis ends mid-stage trial of bladder cancer drug Rubraca citing probable lack of clinical benefit firstwordpharma
April 14, 2019
Clovis Oncology disclosed in a US Securities and Exchange Commission filing on Friday that it is discontinuing the Phase ……
Merck limits orders for bladder cancer drug as demand outstrips supply fiercepharma
March 15, 2019
When Sanofi said it’d stop making a bladder cancer drug in 2016, one expert predicted there’d be shortages. Fast forward to today, and Merck says it’s done it’s best to ensure global supply, but as the lone manufacturer, it’s having trouble keeping up.